药物对比
Erenumab vs Rimegepant
Erenumab（Aimovig）与 Rimegepant（Nurtec）：注射与口服CGRP阻滞剂，用于偏头痛预防和急性治疗。比较疗效和安全性。
此页面暂无可用的对比维度。
临床背景
Patients seeking CGRP-targeted migraine therapies often compare injectable monoclonal antibodies like Erenumab with oral gepants like Rimegepant for prevention or acute treatment.
结论
Selection between Erenumab and Rimegepant should be individualized based on administration route, treatment indication, and patient-specific factors.
全部药物对比